136 related articles for article (PubMed ID: 35641251)
1. Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method.
Saito Y; Takekuma Y; Kobayashi M; Shinagawa N; Noguchi T; Takeuchi S; Shimizu Y; Kinoshita I; Dosaka-Akita H; Sugawara M
Anticancer Res; 2022 Jun; 42(6):3185-3193. PubMed ID: 35641251
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of oral rehydration solution for hydration in cancer chemotherapy: toward the application of outpatient chemotherapy with high-dose Cisplatin therapy-].
Sato J; Kudo K; Hino K; Takahashi K
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1471-6. PubMed ID: 21918344
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancer.
Sato J; Morikawa N; Nitanai H; Nagashima H; Nihei S; Yamauti K; Kudo K
J Pharm Health Care Sci; 2016; 2():6. PubMed ID: 26949541
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis.
Saito Y; Sakamoto T; Takekuma Y; Kobayashi M; Okamoto K; Shinagawa N; Shimizu Y; Kinoshita I; Sugawara M
Sci Rep; 2022 Dec; 12(1):21819. PubMed ID: 36528725
[TBL] [Abstract][Full Text] [Related]
5. Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.
Saito Y; Kobayashi M; Tamaki S; Nakamura K; Hirate D; Takahashi K; Takekuma Y; Sakakibara-Konishi J; Shimizu Y; Kinoshita I; Sugawara M
Sci Rep; 2023 Oct; 13(1):17126. PubMed ID: 37816823
[TBL] [Abstract][Full Text] [Related]
6. Effect of Short Hydration on Cisplatin-Induced Nephrotoxicity in Cancer Patients: A Retrospective Study.
Ashrafi F; Ebrahimi Z; Nematbakhsh M
Int J Hematol Oncol Stem Cell Res; 2017 Oct; 11(4):262-267. PubMed ID: 29340120
[No Abstract] [Full Text] [Related]
7. Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial.
Horinouchi H; Kubota K; Miyanaga A; Nakamichi S; Seike M; Gemma A; Yamane Y; Kurimoto F; Sakai H; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Tamura T; Ohe Y
ESMO Open; 2018; 3(1):e000288. PubMed ID: 29503734
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Prediabetes in Cisplatin-induced Nephrotoxicity in the Short Hydration Method: A Subgroup Analysis.
Saito Y; Sakamoto T; Kobayashi M; Takekuma Y; Higuchi I; Okamoto K; Sakakibara-Konishi J; Shimizu Y; Kinoshita I; Sugawara M
In Vivo; 2024; 38(2):800-806. PubMed ID: 38418143
[TBL] [Abstract][Full Text] [Related]
9. [Nephrotoxicity of a Short Hydration Method for the Cisplatin Regimen in Patients with Gastric Cancer].
Kishi K; Saito T; Mikamori M; Ohtsuka M; Furukawa K; Suzuki Y; Tei M; Tanemura M; Akamatsu H
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2069-2071. PubMed ID: 30692287
[TBL] [Abstract][Full Text] [Related]
10. [Safety Assessment of a Short Hydration Regimen for Outpatient Cisplatin-Based Chemotherapy].
Yoshida H; Kimata T; Suzuki M; Uchida T; Yamamuro O
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1081-5. PubMed ID: 27628548
[TBL] [Abstract][Full Text] [Related]
11. A double-blind clinical trial comparing World Health Organization oral rehydration solution with a reduced osmolarity solution containing equal amounts of sodium and glucose.
Santosham M; Fayad I; Abu Zikri M; Hussein A; Amponsah A; Duggan C; Hashem M; el Sady N; Abu Zikri M; Fontaine O
J Pediatr; 1996 Jan; 128(1):45-51. PubMed ID: 8551420
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of oral supplemental hydration for the prevention of contrast-induced nephropathy in rats.
Matsunami T; Hino K; Dosho R; Miyatake S; Ebisu G; Kuwatsuru R
Jpn J Radiol; 2017 Apr; 35(4):190-196. PubMed ID: 28205100
[TBL] [Abstract][Full Text] [Related]
13. [Utility of the Predictive Score for Cisplatin-Induced Nephrotoxicity in Patients with Chemotherapy for Lung Cancer].
Sakurai T; Takada K; Kojima E; Yamashita Y; Akazawa N; Ito S; Watanabe S
Gan To Kagaku Ryoho; 2019 Dec; 46(12):1849-1853. PubMed ID: 31879402
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non-small cell lung cancer.
Tachihara M; Dokuni R; Okuno K; Tokunaga S; Nakata K; Katsurada N; Yamamoto M; Nagano T; Kobayashi K; Tanaka Y; Funada Y; Maniwa Y; Nishimura Y
Thorac Cancer; 2020 Sep; 11(9):2536-2541. PubMed ID: 32729237
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy of a glucose/glycine/glycylglycine electrolyte solution versus the standard WHO/ORS in diarrheic dehydrated children.
Pizarro D; Posada G; Mahalanabis D; Sandà L
J Pediatr Gastroenterol Nutr; 1988; 7(6):882-8. PubMed ID: 3199275
[TBL] [Abstract][Full Text] [Related]
16. Electrolytes: Oral Electrolyte Solutions.
Harris L; Braun M
FP Essent; 2017 Aug; 459():35-38. PubMed ID: 28806049
[TBL] [Abstract][Full Text] [Related]
17. [Feasibility of short volume hydration in patients with lung cancer treated with Cisplatin-containing chemotherapy].
Ohhara Y; Isobe H; Ito K; Fuke S; Kojima T; Saito H; Nishiura Y
Gan To Kagaku Ryoho; 2015 Jan; 42(1):57-61. PubMed ID: 25596680
[TBL] [Abstract][Full Text] [Related]
18. [Preventive effect of urinastatin on cisplatin induced nephrotoxicity in rabbits].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):328-32. PubMed ID: 2567322
[TBL] [Abstract][Full Text] [Related]
19. A systematic review for prevention of cisplatin-induced nephrotoxicity using different hydration protocols and meta-analysis for magnesium hydrate supplementation.
Li J; Wu Y; Chen C; Zhang W; Yue L; Liu T
Clin Exp Nephrol; 2024 Jan; 28(1):1-12. PubMed ID: 37530867
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of glucose-oral rehydration solution (ORS), rice dextrin-ORS, and rice flour-ORS for the management of children with acute diarrhea and mild or moderate dehydration.
Molina S; Vettorazzi C; Peerson JM; Solomons NW; Brown KH
Pediatrics; 1995 Feb; 95(2):191-7. PubMed ID: 7838634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]